rs6054605

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_033409.4(SLC52A3):​c.645C>T​(p.Pro215Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.064 in 1,613,664 control chromosomes in the GnomAD database, including 6,511 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.067 ( 734 hom., cov: 32)
Exomes 𝑓: 0.064 ( 5777 hom. )

Consequence

SLC52A3
NM_033409.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.72

Publications

10 publications found
Variant links:
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive bulbar palsy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 20-763926-G-A is Benign according to our data. Variant chr20-763926-G-A is described in ClinVar as Benign. ClinVar VariationId is 262237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.72 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.421 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC52A3NM_033409.4 linkc.645C>T p.Pro215Pro synonymous_variant Exon 3 of 5 ENST00000645534.1 NP_212134.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC52A3ENST00000645534.1 linkc.645C>T p.Pro215Pro synonymous_variant Exon 3 of 5 NM_033409.4 ENSP00000494193.1

Frequencies

GnomAD3 genomes
AF:
0.0670
AC:
10181
AN:
152024
Hom.:
735
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0472
Gnomad AMI
AF:
0.0822
Gnomad AMR
AF:
0.0750
Gnomad ASJ
AF:
0.0695
Gnomad EAS
AF:
0.437
Gnomad SAS
AF:
0.0714
Gnomad FIN
AF:
0.0249
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0544
Gnomad OTH
AF:
0.0834
GnomAD2 exomes
AF:
0.0854
AC:
21331
AN:
249854
AF XY:
0.0829
show subpopulations
Gnomad AFR exome
AF:
0.0496
Gnomad AMR exome
AF:
0.0600
Gnomad ASJ exome
AF:
0.0669
Gnomad EAS exome
AF:
0.467
Gnomad FIN exome
AF:
0.0271
Gnomad NFE exome
AF:
0.0577
Gnomad OTH exome
AF:
0.0803
GnomAD4 exome
AF:
0.0637
AC:
93128
AN:
1461522
Hom.:
5777
Cov.:
64
AF XY:
0.0635
AC XY:
46187
AN XY:
727016
show subpopulations
African (AFR)
AF:
0.0465
AC:
1558
AN:
33476
American (AMR)
AF:
0.0592
AC:
2645
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.0662
AC:
1730
AN:
26130
East Asian (EAS)
AF:
0.393
AC:
15601
AN:
39676
South Asian (SAS)
AF:
0.0548
AC:
4721
AN:
86220
European-Finnish (FIN)
AF:
0.0285
AC:
1521
AN:
53392
Middle Eastern (MID)
AF:
0.0914
AC:
527
AN:
5764
European-Non Finnish (NFE)
AF:
0.0537
AC:
59701
AN:
1111832
Other (OTH)
AF:
0.0849
AC:
5124
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
5528
11056
16585
22113
27641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2392
4784
7176
9568
11960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0669
AC:
10183
AN:
152142
Hom.:
734
Cov.:
32
AF XY:
0.0689
AC XY:
5126
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.0473
AC:
1965
AN:
41504
American (AMR)
AF:
0.0748
AC:
1144
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0695
AC:
241
AN:
3470
East Asian (EAS)
AF:
0.436
AC:
2242
AN:
5138
South Asian (SAS)
AF:
0.0718
AC:
347
AN:
4830
European-Finnish (FIN)
AF:
0.0249
AC:
264
AN:
10610
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0544
AC:
3699
AN:
67992
Other (OTH)
AF:
0.0830
AC:
175
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
461
923
1384
1846
2307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0631
Hom.:
2004
Bravo
AF:
0.0729
Asia WGS
AF:
0.195
AC:
675
AN:
3478
EpiCase
AF:
0.0630
EpiControl
AF:
0.0667

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Pro215Pro in exon 3 of SLC52A3: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 46.21% (3846/8322) of East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs6054605).

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Brown-Vialetto-van Laere syndrome 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.43
DANN
Benign
0.63
PhyloP100
-4.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6054605; hg19: chr20-744570; COSMIC: COSV54077373; API